Skip to main content

Dr. John Bonfiglio

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. John Bonfiglio

AI Financial Corp reported in an 8-K filed March 21, 2023 that Dr. John Bonfiglio was appointed Interim President of JanOne Biotech, effective March 15, 2023.

“On March 15, 2023, we appointed Dr. John Bonfiglio as the Interim President of JanOne Biotech and approved the compensation arrangement referenced in Item 1.01 above.”
AI Financial Corp Form 8-K, filed March 21, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at AI Financial Corp

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.